SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-103694
Filing Date
2011-04-20
Accepted
2011-04-20 16:15:30
Documents
4
Period of Report
2011-06-02
Effectiveness Date
2011-04-20

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 581280
2 GRAPHIC g173067g45h63.jpg GRAPHIC 20458
3 GRAPHIC g173067g76q95.jpg GRAPHIC 7377
4 GRAPHIC g173067pc_pg002.jpg GRAPHIC 5151
  Complete submission text file 0001193125-11-103694.txt   628206
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34828 | Film No.: 11770785
SIC: 2834 Pharmaceutical Preparations